The Bull Case For Zenas BioPharma (ZBIO) Could Change Following Its Shift Into Russell Growth Indices
In late June 2026, Zenas BioPharma was removed from several Russell value benchmarks and simultaneously added to multiple Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices. This broad shift from value to growth classifications highlights how index providers now categorize Zenas BioPharma more squarely as a growth-oriented biotech name. Next, we’ll explore how this reclassification into growth indices and the resulting index-tracking fund activity...
In late June 2026, Zenas BioPharma was removed from several Russell value benchmarks and simultaneously added to multiple Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices.
This broad shift from value to growth classifications highlights how index providers now categorize Zenas BioPharma more squarely as a growth-oriented biotech name.
Next, we’ll explore how this reclassification into growth indices and the resulting index-tracking fund activity...
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
